title: Biomarker-driven early lung cancer therapy: the future is now?
authors.affiliation: Department of Thoracic Surgery, Helios University Hospital Wuppertal, University Witten/Herdecke, Wuppertal, Germany servet.boeluekbas@helios-kliniken.de.
authors.forename: Servet
authors.initials: S
authors.lastname: Bölükbas
authors.affiliation: Division of Pulmonary, Critical Care and Occupational Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Eberlein
mesh_terms: D000230:Adenocarcinoma; D014408:Biomarkers, Tumor; D006801:Humans; D008175:Lung Neoplasms; D011379:Prognosis; D055502:Secondary Prevention
chemical_list: D014408:Biomarkers, Tumor
keywords: Adjuvant therapy; GINS complex; Lung adenocarcinoma; Prognostic indicator; Psf3; Tissue microarray